Recombinant Erwinia Asparaginase and Venetoclax in Combination With Blinatumomab for the Treatment of Relapsed or Refractory CD19 Positive B-cell Acute Lymphoblastic Leukemia
City of Hope Medical Center
City of Hope Medical Center
OHSU Knight Cancer Institute
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)